Mission: IDBiologics was founded to discover and develop human monoclonal antibodies (mAbs) for the prevention and treatment of infectious diseases.
World leading platform: Founded from the laboratory of Professor James Crowe at Vanderbilt University Medical Center (VUMC), our innovative fully human mAb platform enables rapid discovery and optimization of broad and potent therapeutic mAbs with neutralizing activity to a range of viral targets.
Diverse pipeline: IDBiologics has a pipeline with unparalleled breadth of therapeutic antibodies for infectious diseases, including 6 clinical lead candidate molecules to diverse targets each with robust animal POC.